Study Bolsters Evidence that Effects of Puberty Blockers Are Reversible

Medications commonly known as puberty blockers were found to delay development of female reproductive organs but allow for restoration of reproductive functioning after the medications were withdrawn, according to a new study being presented this week at the American Physiology Summit.

A third of trans masculine individuals on testosterone ovulate

“Trans masculine people are people born female but do not identify as such, for example they feel male, gender fluid or non-binary. Our examination of their ovarian tissue shows that 33% of them show signs of recent ovulation, despite being on testosterone and no longer menstruating,” says Joyce Asseler, PhD candidate at Amsterdam UMC.

NIH grants support UCLA and Charles Drew University researchers’ efforts to end HIV epidemic

The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

UNFPA and Chulalongkorn Hold a Special Talk on “World Population Day” and Launch “inCUsive” Platform for Sustainable Development

Together with Chulalongkorn University, the UNFPA celebrated World Population Day by holding a panel discussion titled “Bridging Integration Gaps and Promoting Gender Equality for Young People Towards Aged Society,” as well as launching the inCUsive platform to promote sustainable development.

Single hospital study finds transgender teenagers rarely choose to discontinue hormone therapy

A three-year-long retrospective cohort study of a single Atlanta hospital’s patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Prompt testosterone treatment improves mental health of transgender, gender-diverse people

Receiving rapid access to testosterone therapy reduced feelings of gender dysphoria and led to a clinically significant reduction in depression as well as a 50% reduction in suicidality among transgender and gender diverse adults, according to research being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago.

Transgender people seen in the ER much more likely than cisgender people to be admitted to hospital

Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are much more likely to be admitted to the hospital once they visit the ER, according to a study being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

University provost calls out anti-woke/trans movement in Florida

Donald Hall, provost at Binghamton University, State University of New York, just published a powerful op-ed at the Miami Herald that calls out anti-woke/anti-trans policy and hysteria gaining ground in Florida, and calls for those students seeking a positive learning environment…

Microvascular Impairment Caused by Chronic Estrogen Exposure Is Sex-specific

Article title: 17β-estradiol promotes sex-specific dysfunction in isolated human arterioles Authors: Gopika SenthilKumar, Boran Katunaric, Henry Bordas-Murphy, Micaela Young, Erin L. Doren, Mary E. Schulz, Michael E. Widlansky, Julie K. Freed From the authors: “To our knowledge, this is the…

Transgender youth, teens more likely to have sleep disorders

Transgender and gender-nonconforming youth are four times more likely to have a sleep disorder compared to cisgender youth, a Michigan Medicine-led study finds. Researchers also found that those who pursued gender-affirming therapy were half as likely to have any sleep disorder than transgender individuals who did not pursue the therapy, suggesting a possible protective effect.

Gender Affirmation Treatment Delivery Route May Affect Heart Health

Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.

Longer treatment with puberty-delaying medication in transgender youth leads to lower bone mineral density

A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Transgender college students report higher rates of sleep, mental health concerns

Transgender individuals are more likely to experience discrimination, isolation, and lack of social support. This, along with negative psychosocial challenges, such as being denied access to gender-neutral restrooms, combined with being a college student, and you have what associate professor of neurology, Shelley Hershner M.D., calls “a perfect storm” that can contribute to sleep disorders and other mental health concerns.

Endocrine Society opposes Florida Department of Health policy on gender dysphoria treatment for children and adolescents

The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care.

Endocrine Society and partners to intervene in U.K. transgender medicine court appeal

The United Kingdom’s High Court has granted permission for a coalition of LGBTQ+, youth, reproductive health and medical organizations, including the Endocrine Society, to intervene in an appeal of its decision that minors under age 16 likely could not give informed consent for pubertal suppression.

Discriminatory policies threaten care for transgender, gender diverse individuals

The Endocrine Society and the Pediatric Endocrine Society oppose legislative efforts to block transgender and gender diverse individuals from accessing gender-affirming medical and surgical care, the two medical societies said in a joint policy perspective published in The Journal of Clinical Endocrinology & Metabolism.

Endocrine Society opposes Administration’s effort to roll back protections for transgender health

The Endocrine Society is alarmed by the Administration’s proposed rule to roll back protections for transgender individuals and narrow the scope of the Affordable Care Act (ACA), especially during the COVID-19 pandemic, when everyone needs access to health care. The Society calls on the Administration to maintain access to care protections for all, particularly vulnerable populations.